Stock Analysts

CommScope (COMM) Q2 Earnings and Revenues Beat Estimates

CommScope Holding Company, Inc. COMM reported healthy results in the second quarter of 2018, wherein both the top line and bottom line beat the respective Zacks Consensus Estimate. Net Income On a GAAP basis, quarterly net income was $65.9 million or 34 cents per share compared with $55.5 million or 28 cents per share in the year-ago quarter, primarily driven by higher North American sales volumes and cost-reduction initiatives […]

Stock Analysts

Sabre (SABR) Q2 Earnings and Revenues Top Estimates, Up Y/Y

Sabre Corporation SABR reported adjusted earnings per share of 37 cents for second-quarter of 2018 that increased 5.7% on a year-over-year basis and surpassed the Zacks Consensus Estimate of 35 cents. Revenues came in at $984.4 million, up 9.3% from the year-ago quarter, and topped the Zacks Consensus Estimate of $947 million. […]

Stock Analysts

Paycom (PAYC) Q2 Earnings and Revenues Surpass Estimates

Paycom Software PAYC reported impressive second-quarter 2018 results, surpassing the Zacks Consensus Estimate on both counts. The top and the bottom lines also came ahead of the guided range. The company’s non-GAAP earnings per share came in at 59 cents per share, which beat the Zacks Consensus Estimate of 49 cents. […]

Stock Analysts

Looming US Sanctions on Iran Could Boost Oil Stocks: 5 Picks

The United States is gearing up for military action against Iran so that the key trade waterways in the Middle East remain open. There was much tension between the two countries since President Donald Trump backed out of the 2015 Iran nuclear deal in May, but the scenario worsened after Jul 25, when Iran-backed Houthi rebels attacked two Saudi oil tankers that were passing the Bab al-Mandab Strait. Saudi Arabia, a top exporter of crude oil in 2017 (with $133.6 billion exports), is one of the most prominent allies of the United States. […]

Stock Analysts

Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead’s CEO to Exit

Earnings took center stage for the biotech sector this week, with quite a few bigwigs like Gilead Sciences GILD , Amgen AMGN , Vertex Pharmaceuticals VRTX and Celgene CELG coming up with second-quarter results. Apart from these, regular pipeline updates and data read outs were the key highlights of the week. Recap of the Week’s Most Important Stories : Celgene, Vertex, Amgen Impress, Gilead’s CEO to Step Down : While Gilead Sciences ’ second-quarter earnings beat estimates, the year-over-year decline was disappointing as the magnitude of decline in hepatitis C virus (HCV) sales continues to worsen […]

Stock Analysts

AK Steel (AKS) Earnings Miss, Revenues Beat Estimates in Q2

AK Steel Holding Corporation AKS reported net income of $56.6 million or 18 cents per share in the second quarter of 2018, down roughly 27% from net income of $77.2 million or 24 cents recorded in the prior-year quarter. Adjusted earnings of 22 cents per share missed the Zacks Consensus Estimate of 23 cents. Total operating costs in the quarter rose around 14.3% year over year to roughly $1,647.1 million. […]

Stock Analysts

DISH Network (DISH) Q2 Earnings: Is Disappointment in Store?

DISH Network DISH is set to report second-quarter 2018 results on Aug 3. In the trailing four quarters, the company’s earnings have missed the Zacks Consensus Estimate on three occasions, delivering an average negative surprise of 3.80%. In the last reported quarter, DISH delivered a negative earnings surprise of 2.78% […]

Stock Analysts

JetBlue Costs View Bleak on Pilot Contract Ratification

JetBlue Airways Corporation JBLU has issued an update on the third quarter and full-year outlook, following the recent pilot contract ratification. The company expects a one-time expense of $70-$80 million in 2018 including a $50-million ratification incentive among other contractual provisions. Its expectation for non-fuel unit costs remains unaltered in the range of 0-1% (on a compounded basis) for the 2017-2020 period. […]

Stock Analysts

Big 5 Sporting (BGFV) Down on Loss in Q2 and Sales Miss

Big 5 Sporting Goods Corporation BGFV reported dismal second-quarter 2018 results, wherein it recorded loss per share and sales missed estimates. Also, both top and bottom line declined on a year-over-year basis. This apart, management issued third-quarter guidance, which was below the analysts’ expectations […]